|
KMID : 1140120120170030212
|
|
Cancer Prevention Research
2012 Volume.17 No. 3 p.212 ~ p.217
|
|
|
Apoptotic Effect of Mithramycin A via Regulation of Specificity Protein 1 Expression in Oral Squamous Cancer Cells
|
|
Chae Jung-Il
Shim Jung-Hyun
|
|
|
Abstract
|
|
|
|
Mithramycin A (Mith A), an older chemotherapy drug, has been studied as a potential therapeutic agent that may possess anti-tumor activity as well as apoptotic effect in several cancer patients. No related research has been done on the apoptotic effect of Mith A in HN22 and HSC4 oral squamous cancer cells using the specificity protein 1 (Sp1) protein. Hence, here we investigated whether Mith A can inhibit cell growth and regulate Sp1 target proteins by suppressing levels of Sp1 protein in HN22 and HSC4 cells. As a result, oral squamous cancer cell viability was reduced and apoptotic cell death was increased by Mith A. IC50 of Mith A for 48 h treatment in the HN22 and HSC4 cells were calculated to be approximately 25 and 26 nM. Mith A significantly suppressed Sp1 protein expression levels and modulated the expression level of the Sp1 regulatory protein such as p27, p21, cyclin D1, Mcl-1, and survivin in HN-22 and HSC-4 cells. Mith A also induced apoptotic signaling molecules, including: cleavages of Bid, caspase-3, and PARP, and upregulation of Bax in HN22 and HSC4 cells. In conclusion, our results strongly suggest that Mith A regulated proliferation and mediated apoptosis through inhibition of Sp1 in oral squamous cancer cells.
|
|
|
KEYWORD
|
|
|
Mithramycin A, Specificity protein 1, Oral squamous cancer, Apoptosis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|